Multiparameter Immunophenotyping by Flow Cytometry in Multiple Myeloma: The Diagnostic Utility of Defining Ranges of Normal Antigenic Expression in Comparison to Histology

被引:61
作者
Cannizzo, Elisa [1 ,2 ,3 ]
Bellio, Emanuele [3 ]
Sohani, Aliyah R. [1 ,2 ]
Hasserjian, Robert P. [1 ,2 ]
Ferry, Judith A. [1 ,2 ]
Dorn, Michelle E. [1 ,2 ]
Sadowski, Craig [1 ,2 ]
Bucci, Janessa J. [1 ,2 ]
Carulli, Giovanni [3 ]
Preffer, Frederic [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Univ Pisa, Sect Hematol, Dept Oncol Transplant & Advances Med, Pisa, Italy
关键词
multiple myeloma; flow cytometry; ranges of normal antigenic expression; multiparameter flow cytometry; polyclonal plasma cells' immunophenotype; PLASMA-CELL LEUKEMIA; MINIMAL RESIDUAL DISEASE; MONOCLONAL GAMMOPATHY; UNDETERMINED SIGNIFICANCE; BONE-MARROW; UNCERTAIN SIGNIFICANCE; PROGNOSTIC-FACTOR; CD117; EXPRESSION; THERAPY; DIFFERENTIATION;
D O I
10.1002/cyto.b.20517
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
100118 [医学信息学]; 100208 [临床检验诊断学];
摘要
Background: Numerous studies have reported on the immunophenotype of plasma cells (PCs) in monoclonal gammopathy of undetermined significance (MGUS) and in plasma cell myeloma (PCM), but very few have examined the immunophenotype of normal PCs. In this study, an objective definition of normal range of expression for each antigen was found on normal control PCs. Using these new ranges of normal expression (new method) is different from using a static 20% of PCs cut-off for all antigens as described in the literature (traditional method). These newly calculated normal ranges for each antigen were applied to our data, and compared to histologic and immunohistochemical findings. Methods: Bone marrow samples from 46 patients with PC neoplasms and 15 normal controls were studied. A minimum of 100 PC were analyzed for each patient and control sample. An 8-color staining method was applied to study the immunophenotype of PCs, using a BD FACSCanto II. Results: By the new ranges of normality calculated in this study it was determined that different antigens have different level of expression on polyclonal PCs. CD19 correlated with histology by both the traditional and new methods, but had superior correlation by the new method. Conclusions: This report is the first 8-color immunophenotypic study of PCM in which a "range of normal expression" for each antigen is defined. This is a critical step to help distinguish between a normal and neoplastic PC immunophenotype and discern which antigens are of diagnostic importance. (C) 2010 Clinical Cytometry Society
引用
收藏
页码:231 / 238
页数:8
相关论文
共 50 条
[1]
High expression of CD59 and CD55 on benign and malignant plasma cells [J].
Alcindor, T ;
Kimlinger, T ;
Witzig, TE .
LEUKEMIA & LYMPHOMA, 2006, 47 (05) :919-921
[2]
Bataille R, 2006, HAEMATOLOGICA, V91, P1234
[3]
Bataille R, 2005, HAEMATOLOGICA, V90, P706
[4]
The role of chemotherapy in the treatment of multiple myeloma [J].
Bergsagel, DE .
BAILLIERES CLINICAL HAEMATOLOGY, 1995, 8 (04) :783-794
[5]
Two cases of plasma cell leukemia with atypical immunophenotype [J].
Buda, Gabriele ;
Carulli, Giovanni ;
Orciuolo, Enrico ;
Cannizzo, Elisa ;
Zucca, Alessandra ;
Azzara, Antonio ;
Rossi, Angela ;
Galimberti, Sara ;
Cecconi, Nadia ;
Petrini, Mario .
ACTA HAEMATOLOGICA, 2007, 118 (01) :27-29
[6]
Quantitation of CD36 (Platelet Glycoprotein IV) Expression on Platelets and Monocytes by Flow Cytometry: Application to the study of Plasmodium falciparum Malaria [J].
Cserti-Gazdewich, Christine M. ;
Dzik, Walter H. ;
Dorn, Michelle E. ;
Quagliaroli, Robert O. ;
Xu, Songyi ;
Ssewanyana, Isaac ;
Nayyar, Rakesh ;
Preffer, Frederic I. .
CYTOMETRY PART B-CLINICAL CYTOMETRY, 2009, 76B (02) :127-134
[7]
A single-tube six-colour flow cytometry screening assay for the detection of minimal residual disease in myeloma [J].
de Tute, R. M. ;
Jack, A. S. ;
Child, J. A. ;
Morgan, G. J. ;
Owen, R. G. ;
Rawstron, A. C. .
LEUKEMIA, 2007, 21 (09) :2046-U2
[8]
A phase II trial of imatinib in patients with refractory/relapsed myeloma [J].
Dispenzieri, A ;
Gertz, MA ;
Lacy, MQ ;
Geyer, SM ;
Greipp, PR ;
Rajkumar, SV ;
Kimlinger, T ;
Lust, JA ;
Fonseca, R ;
Allred, J ;
Witzig, TE .
LEUKEMIA & LYMPHOMA, 2006, 47 (01) :39-42
[9]
Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation [J].
Ely, SA ;
Knowles, DM .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (04) :1293-1299
[10]
Fonseca R, 2002, CANCER RES, V62, P715